王逸平研究组

中心主任

  • 姓名
  • 电话
  • 邮箱

研究组

暂无研究组

研究中心介绍

王逸平博士,现任中科院上海药物研究所研究员、博士生导师、药理室心血管药理实验室研究组长。兼任中国药理学会理事、《中国药理学报》编委。

1985年毕业于上海第二医科大学(现上海交通大学医学院)医学系本科,获医学学士学位;1988年上海第二医科大学药理学研究生毕业,获医学硕士学位;2001年中科院上海药物研究所药理学博士研究生毕业,获博士学位。1988年进入中科院上海药物研究所工作,从事心血管药理研究。1997年、1999年、2001年和2004年分别在日本九州大学医学院、法国Claude Bernard大学医学院、芬兰赫尔辛基大学生物医学研究所,以及澳大利亚莫那什大学做访问学者。

主要从事天然产物及其衍生物的心血管药理作用和分子机理研究,重点关注动脉粥样硬化发生发展机制及调控研究;脂蛋白相关磷脂酶A2抑制剂研究;胆固醇脂转移蛋白抑制剂研究。

1. “丹参多酚酸盐及注射用丹参多酚酸盐” 获新药证书,证书编号:Z20050258,Z20050259

2. “丹参多酚酸盐及注射用丹参多酚酸盐” 获2007年度 “上海市科学技术奖”技术发明一等奖(20073067-1-R2)

3. 2004年度“上海市药学会药学科技奖二等奖”

4. 2001年度“明治乳业生命科学奖”

  1. Wen-yi Wang, Jie Zhang, Wen-yu Wu, Jie Li, Yan-ling Ma, Wei-hai Chen, Hong Yan, Kai Wang, Wen-wei Xu, Jian-hua Shen, Yi-ping Wang*. Inhibition of Lipoprotein-Associated Phospholipase A2 Ameliorates Inflammation and Decreases Atherosclerotic Plaque Formation in ApoE-Deficient Mice.  PLos ONE  2011; 6(8): e23425
  2. Youli Lu, Narisu Bao, Gereltu Borjihan, Yanling Ma, Miaomiao Hu, Chen Yu, Shuijun Li, Jingying Jia, Ding Yang, Yiping Wang*. Contribution of Carboxylesterase in Hamster to the Intestinal First-Pass Loss and Low Bioavailability of Ethyl Piperate, an Effective Lipid-Lowering Drug Candidate. Drug Metabolism and Disposition 2011; 39: 796–802
  3. Haifei Zhang, Jie Zhang, Ruopeng Zha, Miaomiao Hu, Yiping Wang*. Magnesium lithospermate B decreases [Ca2+]i in endothelial cells by inhibiting K+ currents. Eur J Pharmacol 2011; 650: 285–289
  4. Kou Wang, Xiao-Yu Zhou, Yuan-Yuan Wang, Ming-Ming Li, Yin-Shan Li,⊥ Li-Yan Peng, Xiao Cheng, Yan Li, Yi-Ping Wang*, Qin-Shi Zhao*. Macrophyllionium and Macrophyllines A and B, Oxindole Alkaloids from Uncaria macrophylla.  J Nat Prod  2011; 74:12–15
  5. Hai-fei ZHANG, Xue-qing CHEN, Guo-yuan HU, Yi-ping WANG*. Magnesium lithospermate B dilates mesenteric arteries by activating BKCa currents and contracts arteries by inhibiting KV currents. Acta Pharmacol Sin  2010; 31: 665–670
  6. Wang WY, Li J, Yang D, Xu W, Zha RP, Wang YP*. OxLDL stimulates lipoprotein-associated phospholipase A2 expression in THP-1 monocytes via PI3K and p38 MAPK pathways. Cardiovasc Res  2010; 85: 845-52.
  7. Chen WH, Yang D, Wang WY, Zhang J, Wang YP*. Cellular electrophysiological effects of changrolin in isolated rat cardiac myocytes. Eur J Pharmacol  2010; 647: 139-146.
  8. Li Chen, Li-Jiang Xuan, Yi-Ping Wang*. Effects of Magnesium Lithospermate B and its Analogues on Ca2+ Homeostasis in Cultured Rat Thoracic Aorta Vascular Smooth Muscle Cells.  Planta Med  2009; 75: 1573–1579
  9. Ding Yang, Chen Yu, Shuijun Li, Gangyi Liu, Youli Lu, Yiping Wang*. Liquid chromatography/tandem mass spectrometry for the determination of changrolin in rat plasma: application to a bioavailability study. J Pharm Biomed Anal 2009; 50: 189–193
  10. Li Wang, Qiang Zhang, Xiaochuan Li, Youli Lu, Zhimou Xue, Lijiang Xuan, Yiping Wang*. Pharmacokinetics and metabolism of lithospermic acid by LC/MS/MS in rats. International Journal of Pharmaceutics 2007; 350: 240-6
  11. Xiaochuan Li, Chen Yu, Youli Lu, Yunlong Gu, Jie Lu, Wei Xu, Lijiang Xuan, and Yiping Wang*. Pharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Depside Salts from Salvia miltiorrhiza in Rats. Drug Metabolism and Disposition 2007; 35 (2):234-9
  12. Xiao-Fen Li, Yi-Ping Wang*. Laser Doppler flowmetry for assessment of myocardial microperfusion in the beating rat heart. Vascul Pharmacol  2007; 46: 207–214
  13. Fujun Zhang, Li Dong, Maojun Cai, Jingkang Shen, Yiping Wang*. Heterologous expression of lipoprotein-associated phospholipase A2 in different expression systems. Protein Expression and Purification 2006; 48: 300-306
  14. Fujun Zhang, Yiping Wang*. Cloning, expression and purification of lipoprotein-associated phospholipase A2 in P. pastoris. Molecular Biotechnology 2006; 33: 29-36
  15. Wei Wang, Guoyuan Hu, Yiping Wang*. Selective blockade of L-type calcium current by magnesium lithospermate B in guinea-pig ventricular myocytes. Life Sciences 2006; 78: 2989-2997
  16. 承担的项目:

    1.国家科技重大专项《Lp-PLA2 抑制剂与抗动脉粥样硬化新药研究》

    2.国家科技重大专项《丹参多酚酸盐及其粉针剂的安全性关键技术研究》

    3.上海市科学技术委员会《丹参多酚酸盐及其粉针剂的后续研究》

    4.新药研究国家重点实验室《脂蛋白相关磷脂酶A2对动脉粥样硬化斑块不稳定性的作用研究和天然抑制活性化合物的发现》

    5.国家科技重大专项《抗心律失常药物硫酸舒欣啶的临床研究》

     

    研究室组织结构